S to TVU recognized when the FLS was 3 mm. Ranges from 0 to 12.27 scoring Insler safety assessment of adverse Lenvatinib events were classified by Medical Dictionary for Regulatory activity Th coding. The intensity of t the side effects and their m Possible relationship to study medication were assessed by doctors test. Menstrual cycles were performed by the participants t Possible on diary cards, categorized as none recorded, spotting, light, medium or heavy. Parameters in the laboratory on samples of blood or urine evaluated included H Hematology, liver function and electrolytes, HbA1c, TSH, and virology, coagulation profile and urine, and ferritin. Weight blood pressure, heart rate, and K Body were recorded at screening, may need during the pretreatment and treatment, and at the final visit. Statistical methods and analyzes for the Games of the continuous variables were summary pharmacodynamic parameters for the pretreatment and treatment ZEITR Calculated trees. These parameters were identified with the help of descriptive statistical summary and analysis of variance for differences between the various doses of dienogest. Categorical variables were analyzed by frequency tables. The maximum score Hoogland w During 2 periods of observation may need during the treatment was grouped into three categories. This summary was prepared using the following argument: can a Hoogland score of 1 or 2 indicates the absence of ovarian activity of t or less, a score of 3 or 4 as a residual activity of t Eierst CKE are identified, and grades 5 and 6 show high activity t of Eierst skirts, including normal ovulation. The dose-response was assessed by a proportional odds model with a probit link function. Trichotomized Hoogland Score was used as an ordinal response variable. Statistical analyzes were performed with software version 9.1.3 for the statistical analysis. Given the exploratory nature of this study, all P values and statements of probability, be interpreted with caution. Ma took no For controlled Were applied to the general level of meaning. The Probengr S was determined so that the width of the 100 Pr Diction interval of ovulation in a dose of 2 mg dienogest betr Gt 0.3. Use 0.05, a sample was obtained from 20 subjects per treatment group. Even taking into account a projected dropout rate of 20%, at least 25 participants were planned to be recruited per treatment arm. The results of the study participants a total of 199 subjects were examined, of which 104 were randomized to study were to participate and 102 were new U treatment. The FAS-Bev Lkerung had a median age of 23 years, H Height 170 cm and weight 65 kg. Demographic characteristics were Dienogest similar in all dose groups. No major protocol deviations were observed in 87 of the 104 randomized women, and women were included in the per protocol set. Hoogland score of ovarian activity t. All women were classified as ovulation in the pretreatment period. W During treatment with 0.5 or 1 mg of dienogest were classified as four participants ovulation. No women in h Here dienogest dose groups may need during the observation period in both treatment ovulation. wide. The hypothesis threshold value indicates that the estrogen is carried out the optimum therapeutic window endometriosis by suppression of Performed strogenspiegel sufficient to inhibit the tufts endometrial stimulation.